Decreased neuronal CD200 expression in IL-4-deficient mice results in increased neuroinflammation in response to lipopolysaccharide

Barclay, 2002, CD200 and membrane protein interactions in the control of myeloid cells, Trends Immunol., 23, 285, 10.1016/S1471-4906(02)02223-8 Benveniste, 1992, Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action, Am. J. Physiol., 263, C1, 10.1152/ajpcell.1992.263.1.C1 Benveniste, 2004, Molecular regulation of CD40 gene expression in macrophages and microglia, Brain Behav. Immun., 18, 7, 10.1016/j.bbi.2003.09.001 Bluthe, 2002, Dual effect of central injection of recombinant rat interleukin-4 on lipopolysaccharide-induced sickness behavior in rats, Neuropsychopharmacology, 26, 86, 10.1016/S0893-133X(01)00305-0 Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding, Anal. Biochem., 72, 248, 10.1016/0003-2697(76)90527-3 Broderick, 2002, Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis, Am. J. Pathol., 161, 1669, 10.1016/S0002-9440(10)64444-6 Cao, 2007, Induction of interleukin-1beta by interleukin-4 in lipopolysaccharide-treated mixed glial cultures: microglial-dependent effects, J. Neurochem., 102, 408, 10.1111/j.1471-4159.2007.04588.x Chen, 2005, SOD-1 inhibits FAS expression in cortex of APP transgenic mice, Apoptosis, 10, 499, 10.1007/s10495-005-1879-y Clarke, 2007, The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-beta1–42 in the rat hippocampus in vivo, Neuropharmacology, 52, 136, 10.1016/j.neuropharm.2006.07.031 Costelloe, 2008, IL-1F5 mediates anti-inflammatory activity in the brain through induction of IL-4 following interaction with SIGIRR/TIR8, J. Neurochem., 105, 1960, 10.1111/j.1471-4159.2008.05304.x Dantzer, 2007, Twenty years of research on cytokine-induced sickness behavior, Brain Behav. Immun., 21, 153, 10.1016/j.bbi.2006.09.006 Dantzer, 2008, From inflammation to sickness and depression: when the immune system subjugates the brain, Nat. Rev. Neurosci., 9, 46, 10.1038/nrn2297 Downer, E.J., Cowley, T.R., Lyons, A., Mills, K.H., Berezin, V., Bock, E., Lynch, M.A., 2009. A novel anti-inflammatory role of NCAM-derived mimetic peptide, FGL. Neurobiol. Aging, in press.. Frank, 2007, Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses, Brain Behav. Immun., 21, 47, 10.1016/j.bbi.2006.03.005 Frank, 2006, MRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging, Neurobiol. Aging, 27, 717, 10.1016/j.neurobiolaging.2005.03.013 Hoek, 2000, Down-regulation of the macrophage lineage through interaction with OX2 (CD200), Science, 290, 1768, 10.1126/science.290.5497.1768 Huang, 1999, Cytokine analysis in multiple sclerosis by competitive RT-PCR: a decreased expression of IL-10 and an increased expression of TNF-alpha in chronic progression, Mult. Scler., 5, 342 Iribarren, 2005, IL-4 inhibits the expression of mouse formyl peptide receptor 2, a receptor for amyloid beta1–42, in TNF-alpha-activated microglia, J. Immunol., 175, 6100, 10.4049/jimmunol.175.9.6100 Kentner, 2007, Investigating the hedonic effects of interferon-alpha on female rats using brain-stimulation reward, Behav. Brain Res., 177, 90, 10.1016/j.bbr.2006.10.033 Kitamura, 2000, Interleukin-4-inhibited mRNA expression in mixed rat glial and in isolated microglial cultures, J. Neuroimmunol., 106, 95, 10.1016/S0165-5728(00)00239-3 Laye, 1994, Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice, Brain Res. Mol. Brain Res., 27, 157, 10.1016/0169-328X(94)90197-X Leon, 1999, An antipyretic role for interleukin-10 in LPS fever in mice, Am. J. Physiol., 276, R81 Loane, 2009, Interleukin-4 mediates the neuroprotective effects of rosiglitazone in the aged brain, Neurobiol Aging., 30, 920, 10.1016/j.neurobiolaging.2007.09.001 Lynch, 2007, Eicosapentaenoic acid confers neuroprotection in the amyloid-beta challenged aged hippocampus, Neurobiol. Aging, 28, 845, 10.1016/j.neurobiolaging.2006.04.006 Lyons, 2007, CD200 ligand receptor interaction modulates microglial activation in vivo and in vitro: a role for IL-4, J. Neurosci., 27, 8309, 10.1523/JNEUROSCI.1781-07.2007 Lyons, 2007, IL-4 attenuates the neuroinflammation induced by amyloid-beta in vivo and in vitro, J. Neurochem., 101, 771, 10.1111/j.1471-4159.2006.04370.x Maher, 2005, Downregulation of IL-4-induced signalling in hippocampus contributes to deficits in LTP in the aged rat, Neurobiol. Aging, 26, 717, 10.1016/j.neurobiolaging.2004.07.002 McGeer, 1998, The importance of inflammatory mechanisms in Alzheimer disease, Exp. Gerontol., 33, 371, 10.1016/S0531-5565(98)00013-8 Minogue, 2007, Modulation of amyloid-beta-induced and age-associated changes in rat hippocampus by eicosapentaenoic acid, J. Neurochem., 103, 914, 10.1111/j.1471-4159.2007.04848.x Molina-Holgado, 2000, Involvement of interleukin-1 in glial responses to lipopolysaccharide: endogenous versus exogenous interleukin-1 actions, J. Neuroimmunol., 111, 1, 10.1016/S0165-5728(00)00344-1 Nemzek, 2004, Humane endpoints in shock research, Shock, 21, 17, 10.1097/01.shk.0000101667.49265.fd Nolan, 2005, Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus, J. Biol. Chem., 280, 9354, 10.1074/jbc.M412170200 Nolan, 2004, Evidence of a protective effect of phosphatidylserine-containing liposomes on lipopolysaccharide-induced impairment of long-term potentiation in the rat hippocampus, J. Neuroimmunol., 151, 12, 10.1016/j.jneuroim.2004.02.001 Strle, 2001, Interleukin-10 in the brain, Crit. Rev. Immunol., 21, 427, 10.1615/CritRevImmunol.v21.i5.20 van Dam, 1992, Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness?, Brain Res., 588, 291, 10.1016/0006-8993(92)91588-6 Walker, 2009, Decreased expression of CD200 and CD200 receptor in Alzheimer’s disease: a potential mechanism leading to chronic inflammation, Exp. Neurol., 215, 5, 10.1016/j.expneurol.2008.09.003 Wright, 2000, Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function, Immunity, 13, 233, 10.1016/S1074-7613(00)00023-6 Ye, 1999, Increased interleukin-6 expression by microglia from brain of aged mice, J. Neuroimmunol., 93, 139, 10.1016/S0165-5728(98)00217-3 Ye, 2001, An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice, Neuroimmunomodulation, 9, 183, 10.1159/000049025 Zhao, 2006, Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microglia, J. Neurochem., 99, 1176, 10.1111/j.1471-4159.2006.04172.x